Delivery Order SPE2DB20D1100-SPE2DB24FD4P6

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $59,881.72, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. This is a firm-fixed-price delivery order with a completion date of September 4, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $2,395.74, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has an ultimate completion date of August 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $26,621.36 firm fixed price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8EF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $45,082.30, is a Firm Fixed Price Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical...
This federal contract award is a delivery order valued at $2,770.74 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The delivery order has a firm fixed price and an ultimate completion date of September 17, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTP26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,911.04 delivery order contract is for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of November 22, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office division a $45,349.28 firm-fixed-price delivery order contract for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $77,101.72 delivery order contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award, valued at $46,000.97, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) valued at up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a potential value of $6,534.98 and a completion date of January 25, 2024. The contract is a firm fixed price delivery order, and no set-aside designation was used. Amerisourcebergen Drug Corp, as a prime...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD4P6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $28,097.94, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a period of performance ending on August 27, 2024. This is a Firm Fixed Price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on supporting military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued in the hundreds of millions of dollars, to provide a comprehensive range of medical commodities.

Generated 11/25/24, 9:24 AM